411 related articles for article (PubMed ID: 29053906)
21. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay.
Suh-Lailam BB; Haven TR; Copple SS; Knapp D; Jaskowski TD; Tebo AE
Clin Chim Acta; 2013 Jun; 421():1-6. PubMed ID: 23454475
[TBL] [Abstract][Full Text] [Related]
22. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
23. Elevated Plasma Homocysteine Levels in Anti-N-methyl-D-aspartate Receptor Encephalitis.
Liu L; Liang J; Liu Q; Luo C; Liu J; Fan R; Chen Z; Chen Y; Peng F; Jiang Y
Front Neurol; 2019; 10():464. PubMed ID: 31130913
[No Abstract] [Full Text] [Related]
24. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.
Yu Y; Wu Y; Cao X; Li J; Liao X; Wei J; Huang W
Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of clinical characteristics and outcomes of mechanically ventilated patients with anti-N-methyl-D-aspartate receptor encephalitis].
Zhang Y; Su YY; Gao DQ; Ye H
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):187-192. PubMed ID: 28162168
[No Abstract] [Full Text] [Related]
26. Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis.
Peng Y; Liu B; Pei S; Zheng D; Wang Z; Ji T; Pan S; Shen HY; Wang H
Front Immunol; 2019; 10():905. PubMed ID: 31214158
[TBL] [Abstract][Full Text] [Related]
27. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
28. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.
Zhang Y; Liu G; Jiang M; Chen W; He Y; Su Y
Neurocrit Care; 2018 Oct; 29(2):264-272. PubMed ID: 29651625
[TBL] [Abstract][Full Text] [Related]
29. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation.
Li Y; Yang K; Zhang F; Wang J; Shen H; Liu M; Guo J; Wang J
Front Immunol; 2022; 13():971659. PubMed ID: 36389787
[TBL] [Abstract][Full Text] [Related]
30. Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour.
Wang BJ; Wang CJ; Zeng ZL; Yang Y; Guo SG
J Neurol Sci; 2017 Jun; 377():127-132. PubMed ID: 28477682
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis.
Huang Q; Wu Y; Qin R; Wei X; Ma M
J Neurol; 2016 Dec; 263(12):2446-2455. PubMed ID: 27632180
[TBL] [Abstract][Full Text] [Related]
32. Does MAP2 have a role in predicting the development of anti-NMDAR encephalitis associated with benign ovarian teratoma? A report of six new pediatric cases.
Cundiff CA; Elawabdeh N; Naguib MM; Jactel SN; Demellawy DE; Abramowsky CR; Durham MM; Youssef L; Wittkamp ML; Shehata BM
Pediatr Dev Pathol; 2015; 18(2):122-6. PubMed ID: 25569473
[TBL] [Abstract][Full Text] [Related]
33. Simple and effective serum biomarkers potential for predicting status epilepticus in anti-N-methyl-D-aspartate receptor encephalitis.
Liu Y; Ma L; Ma X; Ma X; Li J; Li D; Lin X; Su Z; Chen X
BMC Neurol; 2022 Jan; 22(1):27. PubMed ID: 35031011
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Wu Q; Xie Q; Liu L; Meng C; Wang J
Mult Scler Relat Disord; 2023 Jun; 74():104697. PubMed ID: 37031550
[TBL] [Abstract][Full Text] [Related]
35. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum levels of the NLRP3 inflammasome are associated with the severity of anti-NMDAR encephalitis in children.
Yang J; Li Y; Luo H; Ma J; Zheng Y; Zhou L; Ding R; Meng L; Zhang X; Jiang Y; Li X; Hong S; Jiang L
Clin Chim Acta; 2023 Nov; 551():117587. PubMed ID: 37813328
[TBL] [Abstract][Full Text] [Related]
37. Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: Correlation with clinical outcome.
Deng B; Liu XN; Li X; Zhang X; Quan C; Chen XJ
J Neuroimmunol; 2017 Apr; 305():84-91. PubMed ID: 28284352
[TBL] [Abstract][Full Text] [Related]
38. Status dystonicus in adult patients with anti-N-methyl-D-aspartate-acid receptor encephalitis.
Zhang Y; Cui L; Chen W; Huang H; Liu G; Su Y; Boltze J
J Neurol; 2023 May; 270(5):2693-2701. PubMed ID: 36810828
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis.
Westman G; Sohrabian A; Aurelius E; Ahlm C; Schliamser S; Sund F; Studahl M; Rönnelid J
J Clin Virol; 2018 Jun; 103():75-80. PubMed ID: 29698873
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis.
Liu B; Ai P; Zheng D; Jiang Y; Liu X; Pan S; Wang H
J Neuroimmunol; 2018 Feb; 315():40-44. PubMed ID: 29306404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
